We are live on ! Find out more
B

Bpifrance Portfolio holdings

AUM $1.65B
1-Year Est. Return 19.85%
This Fund
S&P 500
This Quarter Est. Return
-4.04%
1 Year Est. Return
-19.85%
3 Year Est. Return
-49.36%
5 Year Est. Return
-48.43%
10 Year Est. Return
–
AUM
$4.36B
AUM Growth
-$145M
Cap. Flow
+$21.1M
Cap. Flow %
0.48%
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
–
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
VCYT icon
Veracyte
VCYT
+$21.9M

Top Sells

Rank Stock Value
1
CRSP icon
CRISPR Therapeutics
CRSP
+$777K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 84.86%
2 Materials 7.06%
3 Energy 4.3%
4 Communication Services 2.29%
5 Healthcare 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STLA icon
1
Stellantis
STLA
$16.7B
$3.7B 84.86%
192,703,907
– –
CSTM icon
2
Constellium
CSTM
$4.08B
$308M 7.06%
16,393,903
– –
FTI icon
3
TechnipFMC
FTI
$30.3B
$187M 4.3%
24,688,691
– –
CRTO icon
4
Criteo
CRTO
$1.05B
$99.6M 2.29%
2,718,752
– –
VCYT icon
5
Veracyte
VCYT
$4.62B
$23.3M 0.54%
+501,941
New +$21.9M
VECT
6
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$21.7M 0.5%
2,806,217
– –
SQNS
7
Sequans Communications SA
SQNS
$37.9M
$14.5M 0.33%
132,001
– –
CLLS
8
Cellectis
CLLS
$279M
$5.37M 0.12%
425,726
– –
CRSP icon
9
CRISPR Therapeutics
CRSP
$4.68B
– –
-4,800
Closed -$777K

Similar funds

CCM
Compass Capital Management Minneapolis, Minnesota $1.66B AUM 7.83% 1-Year Est. Return
BFPW
BOK Financial Private Wealth Denver, Colorado $1.66B AUM 18.56% 1-Year Est. Return
PP
Patten & Patten Chattanooga, Tennessee $1.66B AUM 18.12% 1-Year Est. Return
ACM
Anomaly Capital Management New York $1.65B AUM 26.47% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.65B AUM 20.56% 1-Year Est. Return
RIA
Recurrent Investment Advisors Houston, Texas $1.66B AUM 38.27% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
ELI
Empire Life Investments Toronto, Ontario, Canada $1.65B AUM 29.46% 1-Year Est. Return

Bpifrance's Q3 2021 Portfolio in Review

As of Q3 2021, Bpifrance held 9 positions worth $4.36B, down 3.2% from $4.5B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Bpifrance's Q3 2021 filing shows 1 new and 1 closed positions. Its largest new stake was Veracyte: 501,941 shares worth $23.3M. The largest sale was CRISPR Therapeutics, an estimated $777K.

By sector, the portfolio is most concentrated in Consumer Discretionary at 85% of assets, up from 84% a quarter earlier, followed by Materials and Energy.

  • Bpifrance's largest Q3 2021 buy was Veracyte: 501,941 shares worth $23.3M.
  • Bpifrance fully exited CRISPR Therapeutics in Q3 2021, selling an estimated $777K.
  • Bpifrance's ten largest holdings make up 100% of its $4.36B portfolio in Q3 2021.
  • Bpifrance opened 1 new position and closed 1 in Q3 2021.
  • Bpifrance's portfolio value fell 3.2% quarter-over-quarter to $4.36B.

Based on Bpifrance's 13F filing for Q3 2021, filed 15 Nov 2021.